Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

AA-Med Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (151)
ARTG (147)
Cancellation or suspension (4)
Prescription medicine registration (4)
Designation or determination (3)
Face mask cancellation (3)
Australian public assessment report (AusPar) (2)
Prescription medicine decision summary (2)
Face mask non-compliance notice (1)
Prescription medicine evaluation (1)

Date

2026 (1)
2025 (41)
2024 (45)
2023 (43)
2022 (34)
2021 (39)
2020 (28)
2019 (24)
2018 (16)
2017 (21)
2016 (5)
2015 (9)
2014 (1)
2012 (1)
2010 (1)
2009 (2)
2008 (3)

Search

Sponsor content

318 result(s) found, displaying 171 to 180

AA-Med Pty Ltd - Analgesia unit, cryogenic (345170)

30 September 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - Analgesia unit, cryogenic.
ZUBSOLV 11.4/2.9 buprenorphine (as HCl) 11.4 mg / naloxone (as HCl dihydrate) 2.9 mg sublingual tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 May 2022

Cancellation by sponsor

Requested by AA-Med Pty Ltd
ZUBSOLV 5.7/1.4 buprenorphine (as HCl) 5.7 mg / naloxone (as HCl dihydrate) 1.4 mg sublingual tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 May 2022

Cancellation by sponsor

Requested by AA-Med Pty Ltd
ZUBSOLV 2.9/0.71 buprenorphine (as HCl) 2.9 mg / naloxone (as HCl dihydrate) 0.71 mg sublingual tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 May 2022

Cancellation by sponsor

Requested by AA-Med Pty Ltd
ZUBSOLV 1.4/0.36 buprenorphine (as HCl) 1.4 mg / naloxone (as HCl dihydrate) 0.36 mg sublingual tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 May 2022

Cancellation by sponsor

Requested by AA-Med Pty Ltd
ZUBSOLV 0.7/0.18 buprenorphine (as HCl) 0.7 mg / naloxone (as HCl dihydrate) 0.18 mg sublingual tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 May 2022

Cancellation by sponsor

Requested by AA-Med Pty Ltd
ZUBSOLV 8.6/2.1 buprenorphine (as HCl) 8.6 mg / naloxone (as HCl dihydrate) 2.1 mg sublingual tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 May 2022

Cancellation by sponsor

Requested by AA-Med Pty Ltd
AA-Med Pty Ltd - Medical device electrical cable, general purpose (342513)

27 August 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - Medical device electrical cable, general purpose.
AA-Med Pty Ltd - Automatic-inflation electronic sphygmomanometer, portable, arm/wrist (341002)

6 August 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - Automatic-inflation electronic sphygmomanometer, portable, arm/wrist.
AA-Med Pty Ltd - Thermometer, infrared, skin (340892)

5 August 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AA-Med Pty Ltd - Thermometer, infrared, skin.

Pages

First page
Previous page
…
Page 14
Page 15
Page 16
Page 17
Current page 18
Page 19
Page 20
Page 21
Page 22
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.